Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1-like 3 (HNRNPA1L3)

Target
HNRNPA1L3
Molecular classification
Other (Pseudogene or uncharacterized member of hnRNP family)
01

Overview

Heterogeneous nuclear ribonucleoprotein A1-like 3 (HNRNPA1L3) appears to refer to either an uncharacterized gene, a pseudogene, or an alternative name for a non-coding element related to the heterogeneous nuclear ribonucleoprotein (hnRNP) A1 family. In available scientific literature and databases, HNRNPA1L3 lacks direct evidence for being an established protein-coding gene or a validated molecular target. Aliases such as "HNRNPA1P48" suggest it may be a pseudogene (a non-coding DNA sequence similar to a known gene but typically lacking protein-coding function). There are many characterized members of the hnRNP family (such as hnRNP A1, A2/B1, etc.) that participate in RNA binding, splicing, and gene regulation[1][2][3], but HNRNPA1L3 is not among those with clearly documented biological function, molecular activity, or disease associations. No evidence exists for druggability, functional or clinical relevance, or utility as a biomarker.\n\n**Key Notes:**\n- Most likely a pseudogene or a non-coding genomic element.\n- Not recognized as a receptor, enzyme, transporter, or typical drug target.\n- No specific biological functions or disease processes directly attributed to HNRNPA1L3.\n- No drugs, mechanisms of action, biomarkers, or safety concerns reported.\n- The term is likely *incorrect* as a therapeutic target without further experimental validation or clarification.\n\nIf your query relates to **hnRNP A1** (not "A1-like 3"), refer to the parent protein, a well-studied RNA-binding protein involved in splicing, mRNA transport, telomere regulation, and tumor cell metabolism[1][2][3][4]. However, HNRNPA1L3 itself does not appear in major gene, protein, or drug resources as a functional, actionable molecular target.

Other names
HNRNPA1L3HNRNPA1P48Heterogeneous nuclear ribonucleoprotein A1 pseudogene 48hnRNP A1-like 3hnRNP A1 pseudogene 48

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1-like 3 (HNRNPA1L3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1-like 3 (HNRNPA1L3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call